Hublo raises €40.0M Growth round

This reinvestment vehicle from Revaia will support Hublo in a new phase following its sale in 2025, aiming to extend support for the company beyond the initial holding period. The capital infusion will advance the platform's technological infrastructure and fast-track its European expansion strategy through organic market penetration and strategic acquisitions.

Source: https://eu-startups.com/2026/02/03/healthtech-platform-hublo-secures-e40-million-revaia-reinvestment-to-support-post-exit-growth-phase/